 |
4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol |
|---|---|
| Trade Name | |
| Orphan Indication | Angelman syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2016-09-06 00:00:00 |
| Sponsor | Ovid Therapeutics;1460 Broadway;New York, New York, 10036 |
| |
4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol |
|---|---|
| Trade Name | |
| Orphan Indication | Angelman syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2016-09-06 00:00:00 |
| Sponsor | Ovid Therapeutics;1460 Broadway;New York, New York, 10036 |